Decision Time In Healthcare & Biotech
What do these impending decisions mean for healthcare and biotech stocks?
Follow The Smart Money Back Into The Gene Therapy Trend With This Biotech
A year or so ago, the gene therapy trend was hot – until it quickly cooled down. But now may be the time to get back in on this trend, especially with one particular biotech stock.
What Makes This Biotech A “Strong Buy”? An Underappreciated – And Potentially Transformative – Late-Stage Pipeline
The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products.”
Why This Biotech Startup Could Be A Moderna In The Making
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.
New Stocks To Watch In Biotech, Tech, Mining & Green Energy
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.
Does An Upgrade In Relative Strength Make This Biotech A Buy?
“When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.”
Read Up On These 4 Reddit Biotech Penny Stocks
“Because biotech penny stocks tend to fluctuate heavily, adding the layer of Reddit makes them even more volatile. So understanding how to trade penny stocks takes a strong knowledge of both external and internal factors.”
5 Stocks Under $10 With Big Upside Potential – Including 2 Microcap Biotech Stocks
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s… Read More »5 Stocks Under $10 With Big Upside Potential – Including 2 Microcap Biotech Stocks
A “Twist” In Making DNA Means Huge Growth Prospects For This Stock
The synthetic biology company discussed in today’s article is a favorite of ARK Invest CEO Cathie Wood. In fact, it’s the fifth-largest holding in her ARK Genomic Revolution ETF.
Analysts Say This Small-Cap Biopharmaceutical Stock Is A Buy
The small-cap biopharmaceutical stock featured in today’s article is a Buy according to the consensus among analysts, who see upside potential of nearly 200% from current levels.